Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis

Shreya Shambhavi, Aksa Alina Joy, Emilia Wilk, Chirag Shah · 2026

Read Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis by Shreya Shambhavi, Aksa Alina Joy, Emilia Wilk, Chirag Shah (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13661094.txt.

Description

Shreya Shambhavi and co-authors report three cases of liver harm from immune cancer drugs in a 2026 paper. The drugs can inflame the liver and force a pause in cancer care. Steroids are the first treatment, but severe cases often need more help. A second drug that calms the immune system is often used, yet dosing guidance is thin.

All three patients got the second drug after steroids gave little response in three days. Liver tests began to fall within a week of starting it. Values returned to normal over the next one to three months as doses tapered. Two patients relapsed later and improved again when the drug was restarted at lower doses.

Catalog record

CREATORShreya Shambhavi, Aksa Alina Joy, Emilia Wilk, Chirag Shah
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13661094

Browse the full library · About the Tower of Babel